Skip to main content
. 2011 Mar 10;22(12):2661–2666. doi: 10.1093/annonc/mdr011

Table 3.

Best response of von Hippel–Lindau lesions by RECIST after sunitinib treatment

Lesion type No. of lesions Best response, n (%)
Partial response Stable disease Progressive disease
Hemangioblastoma 21 0 19 (91) 2 (9)
Renal cell carcinoma 18 6 (33) 10 (67) 2 (10)
Renal cyst 9 0 9 (100) 0
Retinal angioma 7 0 7 (100) 0
Pancreatic NETs 5 0 5 (100) 0
Pancreatic cyst 3 0 3 (100) 0

NETs, neuroendocrine tumors.